GLP Watchdog

Glow vs Hers

Hers has an open FDA warning letter dated September 9, 2025. Glow has none. On compounded semaglutide injection, the standing prices are within $1 a month of each other: $199 at Glow and $199 at Hers.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Glow / Hers

Glow logo

Glow

7.1/10

Hers logo

Hers

6.8/10

FDA warning letters
None on record
Pharmacy
None named in our record
Lowest standing price
$199/moCompounded semaglutide injection
$199/moCompounded semaglutide injection
States
No state list published
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026
Visit GlowFull review
Visit HersFull review

Neither Glow nor Hers pays us. Links to them earn nothing. Scores: Glow 7.1, Hers 6.8. How we are paid

What the record shows

  1. 01

    Hers has an open FDA warning letter dated September 9, 2025. Glow has none.

  2. 02

    Hers names three pharmacies. Glow names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, the standing prices are within $1 a month of each other: $199 at Glow and $199 at Hers.

  4. 04

    Only Glow lists a price for compounded tirzepatide injection. Only Hers lists a price for brand-name tirzepatide pen.

  5. 05

    Hers lists all 50 states. Glow publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Glow

Hers

Compounded semaglutide injection

$199/mo

$2,388 a year

$199/mo

$2,388 a year

Compounded tirzepatide injection

$349/mo

$4,188 a year

Not sold or not priced
Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Price includes
Medication, clinician visits, shipping
Medication
Billed separately
Not stated
Clinician visits, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
Monthly subscription that renews each billing period until canceled
None
Refunds
A consultation-fee refund is possible when no visit takes place or the prescriber declines; medication refunds go through the dispensing pharmacy, which "generally cannot accept returns once medications have been shipped."
No refund guaranteed once the pharmacy has processed an order

Read off each seller’s own pages. Glow: October 17, 2026. Hers: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Glow

7.1/10
  • No FDA warning letter on record
  • Sells compounded tirzepatide injection, which Hers does not price
  • Price includes clinician visits
  • Names no compounding pharmacy
  • Publishes no state list
Visit Glow

The case for Hers

6.8/10
  • Sells brand-name tirzepatide pen, which Glow does not price
  • Names its compounding pharmacy
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
Visit Hers

Scores

Glow 7.1 · Hers 6.8 out of 10. Six weighted parts.

Value25%

5.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
7.0

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
3.0

The score is the same formula for every seller. Payment does not enter it. Method

Glow vs Hers: questions

Hers has an open FDA warning letter dated September 9, 2025. Glow has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Hers names three pharmacies. Glow names no compounding pharmacy in our record.
Neither, by more than $1 a month. Glow charges $199 a month and Hers $199 a month.
Glow states you can cancel at any time; refunds: a consultation-fee refund is possible when no visit takes place or the prescriber declines; medication refunds go through the dispensing pharmacy, which "generally cannot accept returns once medications have been shipped.". Hers states you can cancel at any time; refunds: no refund guaranteed once the pharmacy has processed an order.
Neither Glow nor Hers pays us. Links to them earn nothing. Scores: Glow 7.1, Hers 6.8.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks